Affinity DataIC50: 0.280nMAssay Description:Ability to inhibit [3H]haloperidol binding to dopamine receptor in rat striatal homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 0.400nMAssay Description:Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 0.610nMAssay Description:Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: 2.80nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.More data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(RAT)
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Affinity for displacement of [3H]-WB-4101 labeled Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:The compound was tested for inhibition of [3H]WB-4101 binding to alpha-1 adrenergic receptor of rat frontal cortexMore data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: 38nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:The compound was tested for inhibition of [3H]QNB binding to Muscarinic acetylcholine receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 54nMAssay Description:The compound was tested for inhibition of [3H]QNB binding to Muscarinic acetylcholine receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 60nMAssay Description:Ability to inhibit [3H]haloperidol binding to dopamine receptor in rat striatal homogenateMore data for this Ligand-Target Pair
Affinity DataIC50: 61nMAssay Description:Inhibition of [3H]haloperidol binding to dopamine receptors in rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: >100nMAssay Description:The compound was tested for inhibition of [3H]QNB binding to Muscarinic acetylcholine receptorMore data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+3nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+3nMAssay Description:The compound was tested for inhibition of rabbit plasma renin.More data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(RAT)
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Affinity for displacement of [3H]-clonidine labeled Dopamine receptor D1More data for this Ligand-Target Pair
Affinity DataIC50: 6.00E+3nMAssay Description:The compound was tested for inhibition of [3H]WB-4101 binding to alpha-1 adrenergic receptor of rat frontal cortexMore data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(RAT)
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Affinity for displacement of [3H]-clonidine labeled Dopamine receptor D1More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(2) dopamine receptor(Rattus norvegicus (rat))
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:In vitro binding affinity against Dopamine receptor D2 by displacement of [3H]-haloperidol from rat striatal membranes.More data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(RAT)
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Affinity for displacement of [3H]-WB-4101 labeled Dopamine receptor D1More data for this Ligand-Target Pair
TargetD(1A) dopamine receptor(RAT)
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Warner-Lambert/Parke-Davis Pharmaceutical Research
Curated by ChEMBL
Affinity DataIC50: >1.00E+4nMAssay Description:Affinity for displacement of [3H]-SCH-23,390 labeled Dopamine receptor D1More data for this Ligand-Target Pair